BGM - BGM Group Ltd Profit before interest, taxes and amortization
Operating cash flow before depreciation reflects the impact of regulatory barriers and clinical trial risks, with the value holding at 0.00. The efficiency of BGM Group Ltd (BGM) is based on the synergy between AI platforms and biopharmaceuticals, which, combined with an impeccable B2B status, provides the company with a pragmatic and sustainable image within the niche orphan drug sector.
BGM Group (BGM) - metric breakdowns and financial figures
- share price and consensus valuation forecast:
- market capitalization statistics:
- book capitalization data:
- business debt structure and liquidity details:
Aggregate Debt to Equity BGM Group Ltd|BGM - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital BGM Group Limited|BGM - Company Aggregate Debts|Debts to Book Capitalization BGM Group|BGM - Company Long-Term Debt|Company Short-Term Loans and Borrowings BGM Group|Quick Liquidity Indicator bgm.ltd
- earnings and valuation multiples indicators:
BGM - Net Profit|Projected Future Earnings BGM Group Ltd|BGM - P/E Multiple|Future Price to Earnings BGM Group Limited|BGM - PEG Multiple|Enterprise Value to EBITDA Multiple BGM Group|BGM - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months BGM Group|BGM - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months bgm.ltd|BGM - Earnings growth in current year|Net earnings per one share growth forecast for next year BGM Group Ltd
- sales and revenue indicators:
Summary company analytics:BGM (BGM Group Ltd)
Professional asset selection is based on analyzing a business's ability to generate cash flow before interest and taxes. By examining the total EBITDA over a period, an investor assesses the operational cycle efficiency of BGM Group Ltd, where stable revenue from heparin production provides the financial foundation for expansion into AI platforms and digital insurance.
Competitors of BGM Group Ltd (BGM)
VRTX (Vertex Corp) - Profit before deduction of interest, taxes, depreciation and amortization|Alnylam Pharmaceuticals - Operating profit EBITDA|Profit before interest, taxes and amortization insmed.com|UTHR: Operating profit EBITDA|Operating profit before amortization BMRN|Operating profit before deduction of amortization BBIO|COGT: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Xeris Biopharma (XERS)|KROS: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA ARCT (Arcturus Therapeutics Holdings Inc.)|Income before deduction of interest, taxes and amortization ETON|Kamada Corp - Operating profit EBITDA|FULC - Operating profit EBITDA|abeonatherapeutics.com (ABEO) - Profit before payment of interest, taxes and amortization|Mereo BioPharma Group plc - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Protalix BioTherapeutics, Inc.|Operating profit before deduction of amortization Pliant Rx (PLRX)|Operating profit EBITDA APLT|Operating profit EBITDA Aileron Therapeutics (RNTX)|Operating profit EBITDA GELS (Gelteq)|Aytu BioPharma Inc - Profit before payment of interest, taxes and amortization|Chemomab - Operating profit EBITDA|Operating profit before depreciation charges SRx Health Solutions Inc. (SRXH)|polyrizon-biotech.com (PLRZ) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Aeterna Zentaris Inc.|Operating profit before deduction of amortization CYTH|INZY: Income before deduction of interest, taxes and amortization|Operating profit EBITDA RPHM|COSCIENS Biopharma Inc (CSCI) - Operating profit before depreciation charges
